EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BioHarvest Sciences's enterprise value is C$169.77 Mil.
BioHarvest Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was C$-10.09 Mil. Therefore, BioHarvest Sciences's EV-to-EBITDA for today is -16.83.
The historical rank and industry rank for BioHarvest Sciences's EV-to-EBITDA or its related term are showing as below:
XCNQ:BHSC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -40.73 Med: -12.79 Max: -8.05
Current: -16.82
During the past 10 years, the highest EV-to-EBITDA of BioHarvest Sciences was -8.05. The lowest was -40.73. And the median was -12.79.
XCNQ:BHSC's EV-to-EBITDA is ranked worse than 100% of 1546
companies
in the Consumer Packaged Goods industry
Industry Median: 10.855
vs XCNQ:BHSC: -16.82
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
BioHarvest Sciences EV-to-EBITDA Historical Data
The historical data trend for BioHarvest Sciences's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioHarvest Sciences's EV-to-EBITDA
For the Packaged Foods subindustry, BioHarvest Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioHarvest Sciences's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where BioHarvest Sciences's EV-to-EBITDA falls into.
BioHarvest Sciences's current Enterprise Value is C$169.77 Mil.
BioHarvest Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-10.09 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
BioHarvest Sciences's PE Ratio for today is calculated as:
BioHarvest Sciences's share price for today is C$0.255.
BioHarvest Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.034.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of BioHarvest Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
BioHarvest Sciences (XCNQ:BHSC) Business Description
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XCNQ:BHSC has been successfully added to your 